Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 154

Sort by

Sort Order Select

Journal Articles

Pentotstatin/TBI Conditioning Is Well-Tolerated and Permits Engraftment of a Second Allogeneic Stem Cell Transplant Following Primary or Secondary Rejection of an Allogeneic Hematopoietic Stem Graft

Ani Gvajaia, MD, Amelia Langston, MD, Natia Esiashvil, MD, Michael Graiser, PhD, Kelly Valla, PharmD, Edmund K. Waller, PhDMD

Blood (2019) 134 (Supplement_1): 5657.

https://doi.org/10.1182/blood-2019-122467

Published: 2019

Journal Articles

Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis

Aleksandra S. Dain, MD, Michelle L. Hermiston, MD PhD, Kristin A. Shimano, MD, Sandhya Kharbanda, MD, Alexis Melton, MD PhD, Jasmeen Dara, MD, James N Huang, MD, Christopher C. Dvorak, MD

Blood (2019) 134 (Supplement_1): 3343.

https://doi.org/10.1182/blood-2019-127397

Published: 2019

Journal Articles

Solid Organ Transplant Rejection Associated with the Use of the Immunomodulatory Drugs (IMIDs)

Michelle Nadeau Nguyen, Afrouz Nayernama, PharmD, Steven Christopher Jones, PharmD, Yvette L. Kasamon, MD, Peter E. Waldron, MD

Blood (2019) 134 (Supplement_1): 2189.

https://doi.org/10.1182/blood-2019-123146

Published: 2019

Journal Articles

Information and Communication Technology Applied to Continuing Quality Improvement for the Care and Cure of Childhood Severe Hematological Disorders in India

Rajat Kumar Agarwal, BS, Rakesh Dhanya, BE, Ankita Kumari, BE, Lalith Parmar, BE, Amit Sedai, BE, Stalin Ramprakash, MD MBBS, C P Raghuram, MD, Pallavi Mehta, MD DM, Deepa Trivedi, MD, Shruthi Jayapal, Sandeep S, Lawrence Faulkner, MD

Blood (2019) 134 (Supplement_1): 3468.

https://doi.org/10.1182/blood-2019-125106

Published: 2019

Journal Articles

Induction of Donor-Specific Immune Tolerance with Clinical MIC Cell Infusion — a Phase I Study (TOL-1)

Christian Morath, MD, Anita Schmitt, MD, Christian Kleist, PhD, Volker Daniel, MD, Gerhard Opelz, MD, Caner Süsal, MD, Florian Kälble, MD, Claudia Sommerer, MD, Lei Wang, MD, Angela Hückelhoven, PhD, Arianeb Mehrabi, MD, Uta Merle, MD, Luiza Pego da Silva, Carsten Müller-Tidow, MD, Martin Zeier, MD, Matthias Schaier, MD, Michael Schmitt, MD PhD, Peter Terness, MD

Blood (2018) 132 (Supplement 1): 4539.

https://doi.org/10.1182/blood-2018-99-113386

Published: 2018

Journal Articles

Donor Lymphocyte Infusion Prevented Late Post-Transplant Rejection in 30 Patients with Thalassemia Major

Jianyun Liao, MD, Xiaoting Liu, Yuelin He, MD, Zhiyong Peng, MD, Huaying Liu, MD, Chunfu Li, MD

Blood (2018) 132 (Supplement 1): 2344.

https://doi.org/10.1182/blood-2018-99-118142

Published: 2018

Journal Articles

Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor — Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts

Joseph R. Leventhal, MD PhD, John P. Galvin, MDMS,MPH, James Mathew, PhD, Lorenzo Gallon, MD, Kadiyala Ravindra, MD, Mitchell E. Horwitz, MD, Michael Abecassis, MD, MBA, Suzanne T Ildstad, MD

Blood (2018) 132 (Supplement 1): 202.

https://doi.org/10.1182/blood-2018-99-118832

Published: 2018

Journal Articles

Patient-Reported Outcome Labeling for Malignant Hematology Drugs Approved in the United States: 2011-2017

Marjorie E Zettler, PhD MPH, Ethan Basch, MD MSc, Chadi Nabhan, MD

Blood (2018) 132 (Supplement 1): 2292.

https://doi.org/10.1182/blood-2018-99-116404

Published: 2018

Journal Articles

Effects of Various ATG Doses on Rejection Rate and Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Peter J. Lang, MD, Friedhelm Schuster, Bernd Gruhn, Roland Meisel, MD, Patrick Schlegel, MD, Anne-Marie Lang, Chihab Klose, Wolfgang Schwinger, MD, Tobias F. Feuchtinger, Prof. Dr. MD, Heiko-Manuel Teltschik, Holger Martinius, Michael Schumm, DVM, Rupert Handgretinger, MD

Blood (2017) 130 (Supplement 1): 3250.

https://doi.org/10.1182/blood.V130.Suppl_1.3250.3250

Published: 2017

Journal Articles

Intensification of Lymphodepletion Optimizes CAR Re-Treatment Efficacy

Haneen Shalabi, DO, Nirali N Shah, MD, Terry J. Fry, MD, Bonnie Yates, RN, Cynthia Delbrook, RN, Constance Yuan, Maryalice Stetler-Stevenson, Sneha Ramakrishna, MD

Blood (2017) 130 (Supplement 1): 3889.

https://doi.org/10.1182/blood.V130.Suppl_1.3889.3889

Published: 2017

Journal Articles

Regulatory T Cells Prevent Donor Cell Rejection in a Mouse Model of Delayed Gestational Age in Utero Hematopoietic Cell Transplantation

John S Riley, BA, Lauren E McClain, MD, John Dimos Stratigis, MD, Haiying Li, Alan W. Flake, MD, William H Peranteau, MD

Blood (2017) 130 (Supplement 1): 4444.

https://doi.org/10.1182/blood.V130.Suppl_1.4444.4444

Published: 2017

Journal Articles

CD4/CD8 T-Cell Selection Enhances CD22 CAR-T Cell Transduction and in-Vivo CAR-T Expansion: Updated Results on Phase I Anti-CD22 CAR Dose Expansion Cohort

Nirali N Shah, MD, Steven L Highfill, PhD, Haneen Shalabi, DO, Bonnie Yates, RN, Eli Kane, Vicki Fellowes, Cynthia Delbrook, RN, Jiaqiang Ren, MD PhD, Jianjian Jin, David Stroncek, MD, Terry J. Fry, MD

Blood (2017) 130 (Supplement 1): 809.

https://doi.org/10.1182/blood.V130.Suppl_1.809.809

Published: 2017

Journal Articles

In Vitro Generation of Human Pluripotent Stem Cell-Derived T Cells for Immunotherapy

Amélie Montel-Hagen, PhD, Christopher S. Seet, MD, Suwen Li, Brent Chick, Patrick Chang, Yuhua Zhu, Chongbin He, Shawn Lopez, Gay M. Crooks, MD

Blood (2017) 130 (Supplement 1): 691.

https://doi.org/10.1182/blood.V130.Suppl_1.691.691

Published: 2017

Journal Articles

Tolerogenic interactions between CD8 + dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts

David Hongo, Xiaobin Tang, Xiangyue Zhang, Edgar G. Engleman, Samuel Strober

Blood (2017) 129 (12): 1718–1728.

https://doi.org/10.1182/blood-2016-07-723015

Published: 2017

Includes: Supplemental data

Journal Articles

Next Generation Veto Cells for Non-Myeloablative Haploidentical HSCT: Combining Anti-Viral and Graft Facilitating Activity

Esther Bachar Lustig, PhD, Noga Or Geva, PhD, Assaf Lask, PhD, Rotem Gidron, MD, Sivan Kagan, PhD, Aloukick Kumar Sinqh, PhD, Yair Reisner, PhD

Blood (2016) 128 (22): 3345.

https://doi.org/10.1182/blood.V128.22.3345.3345

Published: 2016

Journal Articles

Contemporary Conditioning Regimen before Allogeneic Stem Cell Transplantation for Children with Non-Malignant Diseases

Christina Peters, MD, Mary Slatter, MD, Paul Veys, MD Prof., Franco Locatelli, MD, Adriana Balduzzi, MD, M. Akif Yesilipek, Prof. Dr., Jean-Hugues Dalle, MD PhD Prof., Marina Cavazzana, MD PhD, Jaap Jan Boelens, MD PhD, Isaac Yaniv, MD Prof., Ansgar S Schulz, MD PhD Prof., Jacek Wachowiak, Prof MD PhD, Manfred Hoenig, MD, Arjan C Lankester, MD PhD, Benedicte Neven, MD PhD, Eric Beohou, Arnaud Dallisier, Peter Bader, MD, Andrew Gennery, MD

Blood (2016) 128 (22): 3398.

https://doi.org/10.1182/blood.V128.22.3398.3398

Published: 2016

Journal Articles

Natural Killer Cell Activities Against iPSCs-Derived HLA-Knockout Platelets and Megakaryocytes Reveal Perfect Rejection Profiles for Allotransfusion

Daisuke Suzuki, Naoshi Sugimoto, MD PhD, Norihide Yoshikawa, Hiroshi Endo, Sou Nakamura, Akitsu Hotta, Koji Eto, MD PhD

Blood (2016) 128 (22): 3841.

https://doi.org/10.1182/blood.V128.22.3841.3841

Published: 2016

Journal Articles

A Naive NK Cell Repertoire in the Circulation of Haploidentical Stem Cell Donors Pre Mobilization Predicts Rejection of Cord Myeloid Cells in Patients Undergoing Combined Haploidentical and Unrelated Cord Blood HSCT

Mattias Carlsten, MD, PhD, Robert N. Reger, Ritesh Kotecha, Enkhtsetseg Purev, Xin Tian, Roger Kurlander, Georg Aue, Richard W. Childs

Blood (2016) 128 (22): 2199.

https://doi.org/10.1182/blood.V128.22.2199.2199

Published: 2016

Journal Articles

Role of Recipient CD8 + T Cell Exhaustion in the Rejection of Adoptively Transferred Haploidentical NK Cells

Robin Williams, MD MS, Sarah Cooley, MD, Veronika Bachanova, MD, Thomas A Waldmann, MD, Bruce R. Blazar, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD, Michael R. Verneris, MD

Blood (2016) 128 (22): 503.

https://doi.org/10.1182/blood.V128.22.503.503

Published: 2016

Journal Articles

Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft

Javid Gaziev, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Antonella Isgro, MD, Marco Marziali, MD, Marco Andreani, PhD, Cecilia Alfieri, MD, Michela Ribersani, MD, Guido Lucarelli, MD

Blood (2016) 128 (22): 2289.

https://doi.org/10.1182/blood.V128.22.2289.2289

Published: 2016

NARROW

Pentotstatin/TBI Conditioning Is Well-Tolerated and Permits Engraftment of a Second Allogeneic Stem Cell Transplant Following Primary or Secondary Rejection of an Allogeneic Hematopoietic Stem Graft

Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis

Solid Organ Transplant Rejection Associated with the Use of the Immunomodulatory Drugs (IMIDs)

Information and Communication Technology Applied to Continuing Quality Improvement for the Care and Cure of Childhood Severe Hematological Disorders in India

Induction of Donor-Specific Immune Tolerance with Clinical MIC Cell Infusion — a Phase I Study (TOL-1)

Donor Lymphocyte Infusion Prevented Late Post-Transplant Rejection in 30 Patients with Thalassemia Major

Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor — Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts

Patient-Reported Outcome Labeling for Malignant Hematology Drugs Approved in the United States: 2011-2017

Effects of Various ATG Doses on Rejection Rate and Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Intensification of Lymphodepletion Optimizes CAR Re-Treatment Efficacy

Regulatory T Cells Prevent Donor Cell Rejection in a Mouse Model of Delayed Gestational Age in Utero Hematopoietic Cell Transplantation

CD4/CD8 T-Cell Selection Enhances CD22 CAR-T Cell Transduction and in-Vivo CAR-T Expansion: Updated Results on Phase I Anti-CD22 CAR Dose Expansion Cohort

In Vitro Generation of Human Pluripotent Stem Cell-Derived T Cells for Immunotherapy

Tolerogenic interactions between CD8 + dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts

Next Generation Veto Cells for Non-Myeloablative Haploidentical HSCT: Combining Anti-Viral and Graft Facilitating Activity

Contemporary Conditioning Regimen before Allogeneic Stem Cell Transplantation for Children with Non-Malignant Diseases

Natural Killer Cell Activities Against iPSCs-Derived HLA-Knockout Platelets and Megakaryocytes Reveal Perfect Rejection Profiles for Allotransfusion

A Naive NK Cell Repertoire in the Circulation of Haploidentical Stem Cell Donors Pre Mobilization Predicts Rejection of Cord Myeloid Cells in Patients Undergoing Combined Haploidentical and Unrelated Cord Blood HSCT

Role of Recipient CD8 + T Cell Exhaustion in the Rejection of Adoptively Transferred Haploidentical NK Cells

Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only